Found: 7
Select item for more details and to access through your institution.
Personalised reprogramming to prevent progressive pacemaker-related left ventricular dysfunction: A phase II randomised, controlled clinical trial.
- Published in:
- PLoS ONE, 2021, v. 16, n. 12, p. 1, doi. 10.1371/journal.pone.0259450
- By:
- Publication type:
- Article
Diabetes mellitus does not alter mortality or hospitalisation risk in patients with newly diagnosed heart failure with preserved ejection fraction: Time to rethink pathophysiological models of disease progression.
- Published in:
- Diabetes & Vascular Disease Research, 2024, v. 21, n. 2, p. 1, doi. 10.1177/14791641231224241
- By:
- Publication type:
- Article
Atrial fibrillation and risk of progressive heart failure in patients with preserved ejection fraction heart failure.
- Published in:
- ESC Heart Failure, 2022, v. 9, n. 5, p. 3254, doi. 10.1002/ehf2.14004
- By:
- Publication type:
- Article
Effect of disease‐modifying agents and their association with mortality in multi‐morbid patients with heart failure with reduced ejection fraction.
- Published in:
- ESC Heart Failure, 2020, v. 7, n. 6, p. 3859, doi. 10.1002/ehf2.12978
- By:
- Publication type:
- Article
Ischemic Heart Disease Modifies the Association of Atrial Fibrillation With Mortality in Heart Failure With Reduced Ejection Fraction.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Vitamin D deficiency is an independent predictor of mortality in patients with chronic heart failure.
- Published in:
- European Journal of Nutrition, 2019, v. 58, n. 6, p. 2535, doi. 10.1007/s00394-018-1806-y
- By:
- Publication type:
- Article
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction.
- Published in:
- Clinical Research in Cardiology, 2023, v. 112, n. 1, p. 111, doi. 10.1007/s00392-022-02053-8
- By:
- Publication type:
- Article